Blood Draw

Devices | Funding | Pharmacy

Babson Diagnostics $31 Million Series B to Drive
Retailization of Customer-First, Highly Accessible
Diagnostic Blood Testing

Devices | Innovation & Technology

Drawbridge Health Receives FDA 510(k) Clearance for OneDraw™ A1C Test System